A detailed history of Israel Englander (Millennium Management LLC) transactions in Century Therapeutics, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 378,633 shares of IPSC stock, worth $526,299. This represents 0.0% of its overall portfolio holdings.

Number of Shares
378,633
Previous 357,401 5.94%
Holding current value
$526,299
Previous $1.49 Million 35.37%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$2.46 - $4.05 $52,230 - $85,989
21,232 Added 5.94%
378,633 $965,000
Q1 2024

May 15, 2024

BUY
$3.19 - $5.32 $696,826 - $1.16 Million
218,441 Added 157.2%
357,401 $1.49 Million
Q4 2023

Feb 14, 2024

BUY
$1.28 - $3.32 $106,177 - $275,397
82,951 Added 148.1%
138,960 $461,000
Q2 2023

Aug 14, 2023

SELL
$2.91 - $3.53 $56,875 - $68,993
-19,545 Reduced 25.87%
56,009 $176,000
Q1 2023

May 15, 2023

SELL
$3.4 - $5.11 $521,233 - $783,383
-153,304 Reduced 66.99%
75,554 $262,000
Q4 2022

Feb 14, 2023

BUY
$4.84 - $11.58 $780,909 - $1.87 Million
161,345 Added 238.98%
228,858 $1.17 Million
Q3 2022

Nov 14, 2022

BUY
$8.57 - $13.1 $59,527 - $90,992
6,946 Added 11.47%
67,513 $668,000

Others Institutions Holding IPSC

About Century Therapeutics, Inc.


  • Ticker IPSC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,881,800
  • Market Cap $81.8M
  • Description
  • Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy targeting CD19 fo...
More about IPSC
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.